These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2568209)

  • 1. Population pharmacokinetic analysis of bisoprolol.
    Grevel J; Thomas P; Whiting B
    Clin Pharmacokinet; 1989 Jul; 17(1):53-63. PubMed ID: 2568209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance.
    Payton CD; Fox JG; Pauleau NF; Boulton-Jones JM; Ioannides C; Johnston A; Thomas P
    Eur Heart J; 1987 Dec; 8 Suppl M():15-22. PubMed ID: 2897297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single oral dose pharmacokinetics of bisoprolol 10 mg in liver disease.
    Hayes PC; Jenkins D; Vavianos P; Dagap K; Johnston A; Ioannides C; Thomas P; Williams R
    Eur Heart J; 1987 Dec; 8 Suppl M():23-9. PubMed ID: 2897298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.
    Beddies G; Fox PR; Papich MD; Kanikanti VR; Krebber R; Keene BW
    Am J Vet Res; 2008 Dec; 69(12):1659-63. PubMed ID: 19046015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetic Analysis of Bisoprolol in Patients with Stable Coronary Artery Disease.
    Nikolic VN; Jankovic SM; Deljanin-Ilic M; Stojanovic SS; Nikolic ML; Zivanovic S; Stokanovic D; Jevtovic-Stoimenov T; Milovanovic JR
    Eur J Drug Metab Pharmacokinet; 2018 Feb; 43(1):35-44. PubMed ID: 28577178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease.
    Kirch W; Rose I; Demers HG; Leopold G; Pabst J; Ohnhaus EE
    Clin Pharmacokinet; 1987 Aug; 13(2):110-7. PubMed ID: 2887325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute febrile infectious diseases on the oral pharmacokinetics and effects of nitrendipine enantiomers and of bisoprolol.
    Soons PA; Grib C; Breimer DD; Kirch W
    Clin Pharmacokinet; 1992 Sep; 23(3):238-48. PubMed ID: 1355019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetics of Bisoprolol in Hemodialysis Patients with Hypertension.
    Nikolic VN; Jankovic SM; Dimitrijevic ZM; Sokolovic MJ; Andric BR; Petrovic DS; Jevtovic-Stoimenov T; Zivanovic S; Milovanovic JR
    Pharmacology; 2016; 97(3-4):134-7. PubMed ID: 26736018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral pharmacokinetics of bisoprolol in resting and exercising healthy volunteers.
    Le Coz F; Sauleman P; Poirier JM; Cuche JL; Midavaine M; Rames A; Lecocq B; Jaillon P
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):28-34. PubMed ID: 1719288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers.
    Le Jeunne C; Poirier JM; Cheymol G; Ertzbischoff O; Engel F; Hugues FC
    Eur J Clin Pharmacol; 1991; 41(2):171-4. PubMed ID: 1683835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balanced pharmacokinetics and metabolism of bisoprolol.
    Leopold G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S16-20. PubMed ID: 2439789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist.
    Leopold G; Pabst J; Ungethüm W; Bühring KU
    J Clin Pharmacol; 1986; 26(8):616-21. PubMed ID: 2878941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of beta-blocking agents pharmacokinetics in obese and non-obese subjects].
    Cheymol G
    Bull Acad Natl Med; 1990 Oct; 174(7):959-67; discussion 967-8. PubMed ID: 1981983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisoprolol pharmacokinetics and body composition in patients with chronic heart failure: a longitudinal study.
    Cvan Trobec K; Grabnar I; Kerec Kos M; Vovk T; Trontelj J; Anker SD; Rosano G; Lainscak M
    Eur J Clin Pharmacol; 2016 Jul; 72(7):813-22. PubMed ID: 26996442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic variability of routinely administered bisoprolol in middle-aged and elderly Japanese patients.
    Taguchi M; Nozawa T; Igawa A; Inoue H; Takesono C; Tahara K; Hashimoto Y
    Biol Pharm Bull; 2005 May; 28(5):876-81. PubMed ID: 15863897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of acute phase of myocardial infarction with injectable bisoprolol with oral versus].
    Grollier G; Samoyeau R; Potier JC
    Therapie; 1991; 46(2):147-54. PubMed ID: 1675817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.
    Stoschitzky K; Stoschitzky G; Brussee H; Bonelli C; Dobnig H
    Cardiology; 2006; 106(4):199-206. PubMed ID: 16679760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisoprolol--comparative toxicokinetic study after oral and conjunctival administration in beagles.
    Bühring KU; Metallinos A; Jakobs N; von Landenberg F; Merck E
    Lens Eye Toxic Res; 1990; 7(3-4):335-45. PubMed ID: 1983105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic analysis of bisoprolol in type 2 diabetic patients with hypertension.
    Momčilović S; Jovanović A; Radojković D; Nikolić VN; Janković SM; Pešić M; Milovanović JR
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1539-1546. PubMed ID: 32583355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.